Rezolute, Inc. announced the appointment of Sunil Karnawat as Chief Commercial Officer, effective August 18, 2025. Dr Karnawat will lead the company’s commercial strategy as it advances its antibody therapy, ersodetug, through Phase 3 studies.
Company Information
Company
Rezolute
Location
275 Shoreline Dr., Ste. 500
Redwood City, California, United States
About
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI).
Fundz sees it the moment Rezolute changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Redwood CityBiotechnologyHealth CareTherapeuticsBiotechnology Researchresearch